Ascendis Pharma A/S has an average rating of buy and mean price target of $313.31, according to analysts polled by FactSet.

Alumis has an average rating of buy and mean price target of $31.44, according to analysts polled by FactSet.

Roth Capital Partners Adjusts Price Target on Palo Alto Networks to $300 From $210, Maintains Neutral Rating MT 07:53am Stephens Adjusts Price Target on Palo Alto Networks to $400 From $370, Keeps ...

SpaceX has an average rating of overweight and mean price target of $225.87, according to analysts polled by FactSet.

Sovereign bonds are getting slammed globally, as worries over rising prices, policy credibility, and unsustainable debts push government borrowing costs in many major economies to multi-decade ...

Canadian government 10-year bond yields rose 0 basis points to 3.748%. The yield on similar U.S. government benchmark debt ...

KKR & Co. Inc. is a financial services group organized around 2 areas of activity: - insurance (67% of revenues): notably life insurance and pensions. The group also offers reinsurance solutions for ...

US equity futures were mostly flat pre-bell Wednesday as traders observed global bond yields continuing to increase amid ...

Calumet said Wednesday that the US Environmental Protection Agency granted full small refinery exemptions for two of its petitions covering the 2025 compliance year. The company said ...

In this environment, Brent is approaching $94 a barrel, while WTI hit $91.5. 'With the winter season approaching, this new ...

Allogene Therapeutics said Wednesday that Chief Financial Officer Geoffrey Parker will retire on Nov. 6. The company said it is conducting an external search for Parker's successor.

Definitive Healthcare Corp.(NasdaqGS:DH) dropped from Russell 2000 Value Benchmark CI Jun. 29 Definitive Healthcare Faces Rising Competitive Pressures, BofA Says MT Jun. 29 BofA Downgrades Definitive ...